MEDIA

Latest News

Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that enhance patient outcomes and physician experiences.

14 October 2023

Barbie Botox: Long-Lasting Neurotoxin Daxxify Is Giving Botox a Run for its Money

21 September 2023

Five Key Facts To Know About Daxxify For Optimal Results

15 September 2023

Spate: The Top 10 Emerging Beauty Brands by U.S. Google Search Growth

11 September 2023

Revance Therapeutics grows Nashville office, therapeutic pipeline

01 September 2023

Daxxify: Everything to Know About the Longer-Lasting Botox Alternative

23 August 2023

Navigating Daxxify’s Potential in the Aesthetic Landscape

21 August 2023

Every Injectable in Allure Editors’ Faces Right Now

19 August 2023

FDA approves first therapeutic indication for Daxxify for injection for the treatment of cervical dystonia

17 August 2023

DAXXIFY Now FDA-Approved for the Treatment of Cervical Dystonia

15 August 2023

FDA Approves Expanded Indication of DaxibotulinumtoxinA to Treat Cervical Dystonia

15 August 2023

Daxxify Has Just Received FDA-Approval to Treat This Painful Neck Condition

14 August 2023

Revance’s Botox rival gets FDA approval for painful neck muscle condition